Tyrosine-protein phosphatase non-receptor type 12 expression is a good prognostic factor in resectable non-small cell lung cancer
Authors:
Open Access
- 14 March 2015
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (13) , 11704-11713
Abstract
Tyrosine-protein phosphatase non-receptor type 12 (PTPN12) has been considered to be a tumor suppressor in human cancer, but its clinical and prognostic significance in non-small cell lung cancer (NSCLC) has not been well elucidated.Keywords
This publication has 35 references indexed in Scilit:
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivoProceedings of the National Academy of Sciences, 2011
- PTP-PEST controls motility, adherens junction assembly, and Rho GTPase activity in colon cancer cellsAmerican Journal of Physiology-Cell Physiology, 2010
- Tyrosine phosphorylation: thirty years and countingCurrent Opinion in Cell Biology, 2009
- Glycogen synthase kinase 3: more than a namesakeBritish Journal of Pharmacology, 2009
- Glycogen Synthase Kinase-3 Inhibition Induces Glioma Cell Death through c-MYC, Nuclear Factor-κB, and Glucose RegulationCancer Research, 2008
- Tenets of PTEN Tumor SuppressionCell, 2008
- Protein tyrosine phosphatases: from genes, to function, to diseaseNature Reviews Molecular Cell Biology, 2006
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- Expression of an N-Terminally Truncated Form of Human Focal Adhesion Kinase in BrainBiochemical and Biophysical Research Communications, 1993